21 CFR 1107.22

§ 1107.22 Withdrawal by applicant.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 1107.22, § 1107.22 Withdrawal by applicant, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/91517
Permanent ID: ys:prov:91517@1
SHA-256: 6ea38b6f98c0845603eb8384b9044e4c6c6bf32d1f58a1f41f2a91efc51eadd2

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) An applicant may at any time make a written request to withdraw an SE Report for which FDA has not issued an order. The withdrawal request must state: (1) Whether the withdrawal is due to a health or safety concern related to the tobacco product; (2) The submission tracking number; and (3) The name of the new tobacco product that is the subject of the SE Report. (b) An SE Report will be considered withdrawn when FDA issues a notice stating the SE Report has been withdrawn. (c) The SE Report is an Agency record, even if withdrawn. FDA will retain the withdrawn SE Report under Federal Agency records schedules. The availability of the withdrawn SE Report will be subject to FDA's public information regulations in part 20 of this chapter.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.